These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 28369830)

  • 21. Transient-mixed Chimerism With Nonmyeloablative Conditioning Does Not Induce Liver Allograft Tolerance in Nonhuman Primates.
    Chaudhry S; Kato Y; Weiner J; Alonso-Guallart P; Baker S; Woodland DC; Lefkowitch JH; Duran-Struuck R; Sondermeijer HP; Zitsman J; Sears ML; Wu A; Karolewski B; Houck PJ; Martinez M; Kato T; Sykes M; Griesemer AD
    Transplantation; 2020 Aug; 104(8):1580-1590. PubMed ID: 32732835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.
    Oura T; Ko DS; Boskovic S; O'Neil JJ; Chipashvili V; Koulmanda M; Hotta K; Kawai K; Nadazdin O; Smith RN; Cosimi AB; Kawai T
    Cell Transplant; 2016; 25(7):1331-41. PubMed ID: 26337731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
    Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
    Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated Injections of IL-2 Break Renal Allograft Tolerance Induced via Mixed Hematopoietic Chimerism in Monkeys.
    Yamada Y; Nadazdin O; Boskovic S; Lee S; Zorn E; Smith RN; Colvin RB; Madsen JC; Cosimi AB; Kawai T; Benichou G
    Am J Transplant; 2015 Dec; 15(12):3055-66. PubMed ID: 26190648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Reconstitution Kinetics following Intentionally Induced Mixed Chimerism by Nonmyeloablative Transplantation.
    Kim N; Lee H; Shin J; Nam YS; Im KI; Lim JY; Lee ES; Kang YN; Park SH; Cho SG
    PLoS One; 2015; 10(5):e0126318. PubMed ID: 25961559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
    Johnstone BH; Messner F; Brandacher G; Woods EJ
    Front Immunol; 2021; 12():622604. PubMed ID: 33732244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
    Cosimi AB; Sachs DH; Sykes M; Kawai T
    Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance, mixed chimerism and protection against graft-versus-host disease after total lymphoid irradiation.
    Field EH; Strober S
    Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):739-48. PubMed ID: 11375076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.
    El-Cheikh J; Vazquez A; Crocchiolo R; Furst S; Calmels B; Castagna L; Lemarie C; Granata A; Ladaique P; Oudin C; Faucher C; Chabannon C; Blaise D
    Am J Hematol; 2012 Dec; 87(12):1074-8. PubMed ID: 22911907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerance induction via mixed chimerism in vascularized composite allotransplantation: is it time for clinical application?
    Cetrulo CL; Drijkoningen T; Sachs DH
    Curr Opin Organ Transplant; 2015 Dec; 20(6):602-7. PubMed ID: 26536420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerance and chimerism after renal and hematopoietic-cell transplantation.
    Scandling JD; Busque S; Dejbakhsh-Jones S; Benike C; Millan MT; Shizuru JA; Hoppe RT; Lowsky R; Engleman EG; Strober S
    N Engl J Med; 2008 Jan; 358(4):362-8. PubMed ID: 18216356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mixed chimerism through donor bone marrow transplantation: a tolerogenic cell therapy for application in organ transplantation.
    Pilat N; Hock K; Wekerle T
    Curr Opin Organ Transplant; 2012 Feb; 17(1):63-70. PubMed ID: 22186093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient mixed chimerism for allograft tolerance.
    Oura T; Hotta K; Cosimi AB; Kawai T
    Chimerism; 2015 Apr; 6(1-2):21-6. PubMed ID: 26517761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques.
    Zheng HB; Watkins B; Tkachev V; Yu S; Tran D; Furlan S; Zeleski K; Singh K; Hamby K; Hotchkiss C; Lane J; Gumber S; Adams AB; Cendales L; Kirk AD; Kaur A; Blazar BR; Larsen CP; Kean LS
    Am J Transplant; 2017 Mar; 17(3):657-670. PubMed ID: 27500470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helical TomoTherapy Total Lymphoid Irradiation and Hematopoietic Cell Transplantation for Kidney Transplant Tolerance in Rhesus Macaques.
    Kaufman DB; Forrest LJ; Fechner J; Post J; Coonen J; Haynes LD; Haynes WJ; Christensen N; Zhong W; Little CJ; D'Alessandro A; Fernandez L; Brunner K; Jensen K; Burlingham WJ; Hematti P; Strober S
    Transpl Int; 2023; 36():11279. PubMed ID: 37426429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX; Fan LY; Wang Q
    Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of allogeneic CD8+ T-cell response by DZNep controls GVHD while preserving hematopoietic chimerism.
    Wang J; Li L; Xu M; Rong R; Zhu T
    Transplantation; 2013 Nov; 96(9):774-81. PubMed ID: 23900211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.